成人37例与儿童10例新型冠状病毒肺炎的临床特点比较

doi:10.6040/j.issn.1671-7554.0.2020.0740

摘要/Abstract

摘要： 目的探讨新型冠状病毒肺炎(COVID-19)患者儿童病例与成人病例临床特点的差异。方法分析山东大学附属济南市传染病医院收治的47例新型冠状病毒肺炎患者流行病学、临床症状、实验室检查、影像学检查及治疗方案,分为儿童组及成人组,对两组数据进行统计学分析。结果成人组家庭聚集病例多见,儿童组均为家庭内传播病例。儿童组患者发热、咳嗽、咽痛(咽痒)、乏力(肌肉酸痛)症状均低于成年组,差异有统计学意义(P<0.05),而胸闷、胸痛症状与成人组无明显差异;儿童组患者肺部影像学无改变比率高于成人组,差异有统计学意义(P<0.05);儿童组患者心肌酶增高比率高于成人组,差异有统计学意义(P<0.05),而肝酶、肌红蛋白、肌钙蛋白增高比率与成人组无明显差异;儿童组患者C-反应蛋白(CRP)、白介素-6(IL-6)、血清淀粉样蛋白酶A(SAA)增高比率低于成人组,差异有统计学意义(P<0.05);而降钙素原(PCT)增高,白细胞、淋巴细胞计数降低比率与成人组无明显差异;儿童组治疗方案较成人组简单。结论家庭内传播是儿童感染COVID-19的主要途径。相比于成人患者,儿童患者临床症状轻微,CT病变较轻,无明显肝损害及心肌损害,各炎症指标变化不明显。

关键词: 新型冠状病毒肺炎, 临床特点, 儿童病例

Abstract: Objective To explore the differences in clinical characteristics between children and adults with COVID-19. Methods The epidemiological characteristics, clinical symptoms, laboratory results, imaging results and treatment regimens of 37 adult and 10 children cases of COVID-19 were analyzed. Results Family clusters were more common in the adult group, while all children cases were caused by intra-family transmission. The adult group had a significantly higher incidence of symptoms such as fever, cough, pharyngeal pain(pharyngeal itch)and fatigue(muscle soreness)than the children group(P<0.05), while there is no difference in symptoms like chest tightness and chest pain. The children group had a higher rate of non-changing pulmonary imaging than the adult group(P<0.05). The children group had higher increase of myocardial enzyme than the adult group(P<0.05), while there were no differences in the increases of liver enzyme, myoglobin and troponin. The children group had lower increase of CRP, IL-6 and SAA than the adult group(P<0.05), while there were no significant differences in the increase of PCT and decreases of leukocyte and lymphocyte counts. The treatment regimen for the children group was simpler than that for the adults. Conclusion Intra-family transmission is the main way for children to catch COVID-19. Compared with adults, children have milder clinical symptoms, milder CT lesions, no obvious liver and myocardial damage, and no significant changes in inflammatory indicators.

Key words: Coronavirus disease 2019, Clinical characteristics, Children cases

中图分类号:

R512.99

王彬,布学慧,孔祥亘,张照华,吴谙诏,肖迪,蒋雪梅. 成人37例与儿童10例新型冠状病毒肺炎的临床特点比较[J]. 山东大学学报 (医学版), 2020, 58(10): 112-116.

WANG Bin, BU Xuehui, KONG Xianggen, ZHANG Zhaohua, WU Anzhao, XIAO Di, JIANG Xuemei. Comparison of the clinical characteristics between 37 adults and 10 children with COVID-19[J]. Journal of Shandong University (Health Sciences), 2020, 58(10): 112-116.

参考文献

[1] Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [J]. Lancet, 2020, 395(10224): 565-574.
[2] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel 310 coronavirus pneumonia in Wuhan, China: a descriptive study [J]. Lancet, 2020, 395(10223): 507-513.
[3] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J]. Lancet, 2020, 395(10223): 497-506.
[4] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel 314 coronavirus-infected pneumonia in Wuhan, China [J]. JAMA, 2020, 323(11): 1061-1069.
[5] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China [J]. N Engl J Med, 2020, 382(18): 1708-1720.
[6] 国家卫生健康委员会办公厅,国家中医药管理局办公室.新型冠状病毒感染的肺炎诊疗方案(试行第五版)[EB/OL].(2020-02-04)[2020-02-05]. http:/ www.gov.cn/zhengce/zhengceku/2020-02-04/content_ 5474791.htm.
[7] Kuiken T, Fouchier RAM, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome [J]. Lancet, 2003, 362(9380): 263-270.
[8] Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis [J]. J Med Virol, 2020, 92(4): 418-423.
[9] Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome [J]. N Engl J Med, 2003, 348(20): 1967-1976.
[10] Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia [J]. N Engl J Med, 2012, 367(19): 1814-1820.
[11] Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses [J]. Trends Microbiol, 2016, 24: 490-502. doi: 10.1016/j.tim.2016.03.003.8.
[12] De Groot RJ, Baker SC, Baric RS, et al. Middle East respiratory syndrome coronavirus(MERS-CoV): announcement of the Coronavirus Study Group [J]. J Virol, 2013, 87: 7790-7792. doi: 10.1128/JVI.01244-13.
[13] Graham RL, Donaldson EF, Baric RS. A decade after SARS: strategies for controlling emerging coronaviruses [J]. Nat Rev Microbiol, 2013, 11(12): 836-848.
[14] Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV [J]. Viruses, 2020, 12(2): 135.
[15] 中国疾病预防控制中心NCIP疫情应对流行病学工作组.中国2019年新冠病毒疫情暴发流行病学特征 [J]. 中华流行病学杂志, 2020,41(2):145-151.
[16] Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [J]. Lancet, 2020, 395(10223): 514-523.
[17] Stockman LJ, Massoudi MS, Helfand R, et al. Severe acute respiratory syndrome in children [J]. Pediatr Infect Dis J, 2007, 26(1): 68-74.
[18] Thabet F, Chehab M, Bafaqih H, et al. Middle East respiratory syndrome coronavirus in children [J]. Saudi Med J, 2015, 36(4): 484-486.
[19] Huang J, Cao Y, Bu X, et al. Residue analysis of a CTL epitope of SARSCoV spike protein by IFN-gamma production and bioinformatics prediction [J]. BMC Immunology, 2012, 13: 50. doi:10.1186/1471-2172-13-50.
[20] Younan P, Iampietro M, Nishida A, et al. Ebola virus binding to tim-1 on T lymphocytes induces a cytokine storm [J]. mBio, 2017, 8(5): e00845-17. doi: 10.1128/mBio.00845-17.
[21] La Gruta NL, Kedzierska K, Stambas J, et al. A question of self-preservation: immunopathology in influenza virus infection [J]. Immunol Cell Biol, 2007, 85(2): 85-92.
[22] 王曼芝,张启倬,胡尔林,等.106例正常儿童心肌酶正常值调查分析[J] ,中国当代儿科杂志,2002,4(1):73-75.
[23] Elamm C, Fairweather D, Cooper LT. Pathogenesis and diagnosis of myocarditis [J]. Heart, 2012, 98(11): 835-840.
[24] Le RD, Kosowsky JM, Landman AB, et al. Clinical and financial impact of removing creatine kinase-mb from the routine testing menu in the emergency setting [J]. Am J Emerg Med, 2015, 33(1): 72-75.
[25] Korppi M. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination? [J]. Pediatr Int, 2004, 46(5): 545-550.

相关文章 15

[1]	王玉淼,崔晓霈,张红雨. 高龄老年新型冠状病毒肺炎患者应用抗凝治疗的短期疗效和安全性[J]. 山东大学学报 (医学版), 2024, 62(12): 21-31.
[2]	王园园,孙云. 合并新型冠状病毒肺炎的维持性血液透析患者死亡危险因素[J]. 山东大学学报 (医学版), 2023, 61(11): 68-73.
[3]	孔昕欣,孙书珍,李倩,陈元,周爱华,王莉,姚秀俊. 抗H因子抗体阳性溶血尿毒综合征7例分析[J]. 山东大学学报 (医学版), 2022, 60(4): 82-86.
[4]	曹义海. 血管生成在疾病治疗中的应用与展望[J]. 山东大学学报 (医学版), 2021, 59(9): 9-14.
[5]	杨璇,李岩志,马伟,贾崇奇. 基于两样本孟德尔随机化的肺功能与新型冠状病毒肺炎病死风险的因果关系[J]. 山东大学学报 (医学版), 2021, 59(7): 104-111.
[6]	周溪,黄霂晗,任玉洁,邱洋. 新型冠状病毒感染与天然免疫及炎症反应[J]. 山东大学学报 (医学版), 2021, 59(5): 15-21.
[7]	于莹,张功,刘晶,颜世童,韩涛,黄海量. 基于网络药理学和分子对接方法探析黄芪预防新型冠状病毒肺炎的潜在作用机制[J]. 山东大学学报 (医学版), 2021, 59(4): 6-16.
[8]	罗应舒,李宾,许昌芹,姜军梅,许洪伟. 240例上消化道黏膜下肿瘤内镜治疗的疗效及并发症评估[J]. 山东大学学报 (医学版), 2021, 59(3): 74-80.
[9]	任敏敏,王广梅,张丽,杨瑶瑶,封丹珺. 335名抗疫一线护理人员心理弹性对共情疲劳的影响[J]. 山东大学学报 (医学版), 2021, 59(2): 88-94.
[10]	程召平,段艳华,姚金坤,李岩,顾慧,袁宪顺,刘斌,毕万利,宋照亮,聂佩,陈月芹,孙占国,刘善平,王鲁光,唐忠仁,魏相磊,董亮,王春亭,王锡明. 105例新型冠状病毒肺炎胸部CT影像学特征——山东省多中心回顾性分析[J]. 山东大学学报 (医学版), 2020, 58(5): 38-45.
[11]	袁勇贵,李磊,沈仲夏,陈刚,吴义高,岳莹莹. 新型冠状病毒肺炎疫情下精神障碍诊疗的防控策略[J]. 山东大学学报 (医学版), 2020, 58(4): 1-6.
[12]	常彩云,于秋燕,赵小冬,王芳,李伟,阮师漫,耿兴义. 济南市首例新型冠状病毒肺炎病例及其相关家庭聚集性疫情分析[J]. 山东大学学报 (医学版), 2020, 58(4): 7-11.
[13]	杨丽,李战,刘晓雪,焦海涛,周林,刘庆皆,刘铁诚,耿兴义. 济南市新型冠状病毒肺炎密切接触者隔离医学观察情况分析与评价[J]. 山东大学学报 (医学版), 2020, 58(4): 12-16.
[14]	乔宇,崔亮亮,李帅,王峰,阮师漫,景一鸣,刘翀. 智能问答机器人系统研发及应用研究——以济南市新型冠状病毒肺炎疫情处置应对为例[J]. 山东大学学报 (医学版), 2020, 58(4): 17-22.
[15]	李新蕊,耿兴义,赵小冬,刘岚铮,王蔚茹,崔亮亮,李战,常彩云,阮师漫. 济南市47例新型冠状病毒肺炎疫情流行综合分析[J]. 山东大学学报 (医学版), 2020, 58(4): 23-27.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed